How valid are animal models to evaluate treatments for pulmonary hypertension?
about
A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Tissue factor pathway inhibitor overexpression inhibits hypoxia-induced pulmonary hypertension.Systems approach to the study of stretch and arrhythmias in right ventricular failure induced in rats by monocrotalineA low mortality model of chronic pulmonary hypertension in sheep.Enhanced store-operated Ca²+ entry and TRPC channel expression in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats.Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression.Effect of small hairpin RNA targeting endothelin-converting enzyme-1 in monocrotaline-induced pulmonary hypertensive rats.Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension.MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.The right ventricle: biologic insights and response to disease: updated.Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertensionComparison of 3 methods to induce acute pulmonary hypertension in pigs.RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension.BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus.Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression.The cancer paradigm of severe pulmonary arterial hypertension.Early inflammatory response during the development of right ventricular heart failure in a rat model.A novel murine model of severe pulmonary arterial hypertension.Skeletal muscle mitochondrial dysfunction precedes right ventricular impairment in experimental pulmonary hypertension.Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats.The effects of gender difference on monocrotaline-induced pulmonary hypertension in rats.Association between a Single Nucleotide Polymorphism in the 3'-UTR of and the Risk of Nonidiopathic Pulmonary Arterial Hypertension in Chinese Population
P2860
Q27026643-2947F8F4-522D-4442-A16C-439B247F25B4Q34026306-E8C942F2-FCDF-4D61-88A9-A673DC003358Q34410906-3FC2A02D-1878-432D-BEA8-F178250124CCQ35147704-C2223CEA-27C5-4FA2-86F5-66C4FE59E838Q35895691-62559DC7-C58A-48AC-B502-BD3899CDE4DBQ36375047-258C1120-73A4-47D7-BFF2-B07C1F903B9CQ36472968-310A8121-5057-4277-B018-DF69B6D27DF4Q36494495-7787FB85-B453-447A-AB07-E2F839B6A08FQ36528033-F24E7191-48E4-42F0-BF26-3F78140A4C2CQ36644859-3720A381-93AD-46F9-A7EB-FE464619DA67Q36739882-C161F249-2BD6-4259-A778-AC50868EC5B9Q37322385-70B6C077-0516-4B20-A01C-6A7905917EE1Q37586828-86402FFC-E0AB-4A69-817E-6F83221BE948Q38817806-C495F73C-CDDD-4FF9-BD1D-3922E741BBAFQ41888223-A74A801E-8A2A-47F7-9E9B-74F7606B773BQ42084111-3CFB5AB6-DE0A-4AFD-B668-F176ED169A4AQ42682888-663D77D7-6B19-4C73-A8E6-6607E42F9471Q43056274-CE449CB0-5D9C-46C5-9543-14E78F160B16Q43409467-DD0C2E7C-8372-4D1C-80B0-773689A23FD5Q46015415-F84BDEAF-EF28-4001-892E-01FBA83130C6Q46930202-F92D6B88-3245-4F36-AEC7-C787B71F7257Q51227888-98347BFB-66A5-423E-87A5-4ED232CC5FA4Q58567359-2CFD1E4E-AD6F-4EA9-9B16-4C2747ABECD6
P2860
How valid are animal models to evaluate treatments for pulmonary hypertension?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
How valid are animal models to evaluate treatments for pulmonary hypertension?
@ast
How valid are animal models to evaluate treatments for pulmonary hypertension?
@en
type
label
How valid are animal models to evaluate treatments for pulmonary hypertension?
@ast
How valid are animal models to evaluate treatments for pulmonary hypertension?
@en
prefLabel
How valid are animal models to evaluate treatments for pulmonary hypertension?
@ast
How valid are animal models to evaluate treatments for pulmonary hypertension?
@en
P2093
P1476
How valid are animal models to evaluate treatments for pulmonary hypertension?
@en
P2093
Hanno L Tan
Maria E Campian
Maxim Hardziyenka
P2888
P304
P356
10.1007/S00210-006-0087-9
P577
2006-09-01T00:00:00Z